MarketPulse

BLA

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Inovio Faces Securities Class Action Over Vaccine Device Defects, Regulatory Claims

Rosen Law Firm seeks lead plaintiffs in securities class action against Inovio Pharmaceuticals for alleged misstatements on device defects, regulatory prospects, and product timelines. Lead plaintiff deadline: April 7, 2026.
INOsecurities class actionmisleading statements
BenzingaBenzinga··Business Wire

Savara Clears FDA Hurdle for MOLBREEVI as Drug Advances Toward Autoimmune PAP Approval

Savara receives FDA Day 74 Letter for MOLBREEVI with no advisory committee meeting planned. PDUFA target date set for August 2026.
SVRAFDA approvalMOLBREEVI